Enter assignee name

CIPO Patents = 4

Forward Citations = 436

Loading Chart...

6 inventors (with patents filed for the assignee):

Ghassan S Kassab (27 out of 235 patents)

Xiao Lu (4 out of 15 patents)

Yunlong Huo (2 out of 5 patents)

4. Jose Antonio Navia (2 out of 98 patents)

5. Thomas Wischgoll (1 out of 1 patent)

27 patents: Sort by Forward Citations

1. 10500036 - Tissue engineering of blood vessels (2019-12-10),

2. 10401348 - Methods to determine fluid filtration rates through mammalian luminal organs (2019-09-03),

3. 10369098 - Methods for localized drug delivery (2019-08-06),

4. 10314686 - Devices, systems and methods for tissue engineering of luminal grafts (2019-06-11),

5. 10265100 - Transradial access devices, systems, and methods (2019-04-23),

6. 10219828 - Devices, systems, and methods for transradial access (2019-03-05),

7. 10217220 - Methods for the determination of transit time in circulatory systems and applications of the same (2019-02-26),

8. 9775576 - Systems and methods for applying scaling laws of tree structures (2017-10-03),

9. 9591994 - Systems and methods to obtain a myocardial mass index indicative of an at-risk myocardial region (2017-03-14),

10. 9179996 - Tissue engineering of blood vessels (2015-11-10),

11. 9089282 - Devices and systems to size a luminal organ (2015-07-28),

12. 8998816 - Devices, systems and methods for isometric and isotonic contraction of blood vessels using an isovolumetric myograph (2015-04-07),

13. 8992444 - Devices, systems, and methods for determining isometric and isotonic activity of luminal organs (2015-03-31),

14. 8913060 - Systems and methods for extracting a curve-skeleton from a volumetric image of a vessel (2014-12-16),

15. 8903472 - Applications of scaling laws of tree structures (2014-12-02),

DTherapeutics, LLC is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of various diseases. With a deep commitment to improving patient outcomes, DTherapeutics leverages cutting-edge technologies and scientific expertise to develop novel drugs and therapies. Through strategic partnerships and collaborations, the company aims to bring transformative treatments to market and make a positive impact on the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.